DK1539808T3 - GM-negativ EHV-mutanter uden heterologe elementer - Google Patents

GM-negativ EHV-mutanter uden heterologe elementer

Info

Publication number
DK1539808T3
DK1539808T3 DK03765007T DK03765007T DK1539808T3 DK 1539808 T3 DK1539808 T3 DK 1539808T3 DK 03765007 T DK03765007 T DK 03765007T DK 03765007 T DK03765007 T DK 03765007T DK 1539808 T3 DK1539808 T3 DK 1539808T3
Authority
DK
Denmark
Prior art keywords
ehv
heterologous elements
viruses
negative ehv
mutants
Prior art date
Application number
DK03765007T
Other languages
English (en)
Inventor
Antonie Neubauer
Christina Ziegler
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Application granted granted Critical
Publication of DK1539808T3 publication Critical patent/DK1539808T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16061—Methods of inactivation or attenuation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK03765007T 2002-07-19 2003-07-16 GM-negativ EHV-mutanter uden heterologe elementer DK1539808T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2002133064 DE10233064A1 (de) 2002-07-19 2002-07-19 gM-negative EHV-Mutanten ohne heterologe Elemente
PCT/EP2003/007730 WO2004009802A2 (en) 2002-07-19 2003-07-16 gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS

Publications (1)

Publication Number Publication Date
DK1539808T3 true DK1539808T3 (da) 2009-07-27

Family

ID=30010261

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03765007T DK1539808T3 (da) 2002-07-19 2003-07-16 GM-negativ EHV-mutanter uden heterologe elementer

Country Status (17)

Country Link
EP (1) EP1539808B1 (da)
JP (2) JP4688491B2 (da)
KR (2) KR101111998B1 (da)
CN (4) CN101711864A (da)
AT (1) ATE427958T1 (da)
AU (1) AU2003258517B2 (da)
BR (1) BR0312787A (da)
CA (1) CA2493406C (da)
CY (1) CY1109206T1 (da)
DE (2) DE10233064A1 (da)
DK (1) DK1539808T3 (da)
ES (1) ES2324406T3 (da)
MX (1) MXPA05000592A (da)
PL (1) PL208225B1 (da)
PT (1) PT1539808E (da)
SI (1) SI1539808T1 (da)
WO (1) WO2004009802A2 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1129722A1 (en) 2000-02-17 2001-09-05 Boehringer Ingelheim Vetmedica Gmbh gM-negative EHV-mutants
AR040601A1 (es) 2002-07-19 2005-04-13 Boehringer Ingelheim Vetmed Mutantes ehv negativos de gm sin elementos heterologos
CN101926560A (zh) * 2010-08-31 2010-12-29 苏州星岛金属制品有限公司 可伸缩的凳子
MX2019003160A (es) * 2016-09-20 2019-05-27 Boehringer Ingelheim Vetmedica Gmbh Nuevos promotores.
AU2022321826A1 (en) 2021-08-06 2024-01-25 Intervet International B.V. Vaccine for equine herpesvirus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6193983B1 (en) * 1992-06-01 2001-02-27 The University Of Melbourne Equine herpesvirus glycoproteins
EP1129722A1 (en) * 2000-02-17 2001-09-05 Boehringer Ingelheim Vetmedica Gmbh gM-negative EHV-mutants

Also Published As

Publication number Publication date
EP1539808B1 (en) 2009-04-08
CY1109206T1 (el) 2014-07-02
WO2004009802A2 (en) 2004-01-29
KR20050055689A (ko) 2005-06-13
CN101712949B (zh) 2013-07-03
DE60327082D1 (de) 2009-05-20
AU2003258517B2 (en) 2009-05-07
SI1539808T1 (sl) 2009-08-31
WO2004009802A3 (en) 2005-04-21
ES2324406T3 (es) 2009-08-06
CA2493406C (en) 2013-02-26
JP5469444B2 (ja) 2014-04-16
PT1539808E (pt) 2009-05-21
CN101711864A (zh) 2010-05-26
KR101167576B1 (ko) 2012-08-01
KR101111998B1 (ko) 2012-02-15
PL208225B1 (pl) 2011-04-29
CN1668736A (zh) 2005-09-14
EP1539808A2 (en) 2005-06-15
JP2010057512A (ja) 2010-03-18
DE10233064A1 (de) 2004-02-05
CN102978168A (zh) 2013-03-20
CN101712949A (zh) 2010-05-26
JP4688491B2 (ja) 2011-05-25
PL374574A1 (en) 2005-10-31
BR0312787A (pt) 2005-05-03
AU2003258517A1 (en) 2004-02-09
CA2493406A1 (en) 2004-01-29
ATE427958T1 (de) 2009-04-15
KR20110007629A (ko) 2011-01-24
MXPA05000592A (es) 2005-04-28
JP2005532819A (ja) 2005-11-04

Similar Documents

Publication Publication Date Title
MX2008013993A (es) Combinación adyuvante sinergistica de anticuerpo agonista de cd40/interferona tipo 1, conjugados que la contienen y uso de los mismos como un terapeutico para aumentar la inmunidad celular.
UA96113C2 (en) Inhibitors of caspases
NO20045521L (no) Diarylureaderivater anvendelige for behandling av proteinkinaseavhengige sykdommer
EP1408986A4 (en) PROTEOMIMETIC COMPOUNDS AND CORRESPONDING METHODS
DE60332358D1 (de) Protease-resistente modifizierte interferon alpha polypeptide
DE602004024572D1 (de) Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen
WO2005016962A3 (en) Compositions and methods for the treatment of immune related diseases
DE60327999D1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
ES2094004T3 (es) Uretanos y ureas que inducen la produccion de citoquinas.
DE602004014117D1 (de) Thiazole zur verwendung als inhibitoren von protein-kinasen
MXPA02011545A (es) Virus del sindrome respiratorio y reproductor porcino (peesv), vacuna recombinante para el virus de la viruela.
CY1109206T1 (el) gM- ΑΡΝΗΤΙΚΟΙ EHV-ΜΕΤΑΛΛΑΚΤΕΣ ΧΩΡΙΣ ΕΤΕΡΟΛΟΓΑ ΣΤΟΙΧΕΙΑ
MXPA05005202A (es) Vacuna.
HRP20100473T1 (hr) Imunostimulatorne kombinacije za profilaksu i liječenje hepatitisa c
BR0211761A (pt) depsipeptìdeos e processos para preparar os mesmos
ATE473236T1 (de) Antigene von piscirickettsia salmonis und deren verwendung
DE69732712D1 (de) INHIBITOREN DES INTERLEUKIN-1beta KONVERTIERENDEN ENZYMS
ATE549353T1 (de) Aktive varianten des il-18 bindenden proteins und dessen medizinische verwendungen
HK1121670A1 (en) Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use
NO20060675L (no) Forbedrede, rekombinante, humane interferon-beta-lb-polypeptider
AR040601A1 (es) Mutantes ehv negativos de gm sin elementos heterologos
CY1109023T1 (el) Gm-αρνητικα μεταλλαγματα ehv
DE60325838D1 (de) Imidazoquinolinamine als adjuvantien für hiv dna vakzine
WO2004082596A3 (en) Yersinia species compositions
ATE378351T1 (de) Therapeutische impfzusammensetzung zur verhütung und behandlung von erkrankungen bei säugetieren